The dra gene cluster, expressed by uropathogenic Escherichia coli strains, determines bacterial attachment and invasion. The Dr fimbrial structures formed at the bacterial cell surface are composed of DraE subunits. The Dr fimbriae-coding cluster contains six open reading framesdraA, draB, draC, draD, draP and draE -among which the draE gene encodes the structural fimbrial subunit DraE. Very little is known about E. coli surface expression of the draD gene product. The expression of DraD and its role in the biogenesis of Dr fimbriae were determined by constructing mutants in the dra operon and by immunoblot and immunofluorescence experiments. In this study, DraD was found to be a surface-exposed protein. The expression of DraD was independent of the DraC usher and DraE fimbrial subunits. Polymerization of DraE fimbrial subunits into fimbrial structures did not require expression of the DraD protein.
INTRODUCTION
Adhesion to and invasion of host tissues are crucial steps in the pathogenesis of many bacteria, parasites and viruses. Most of the proteins involved in adhesion and invasion are anchored to the surface of bacteria. Adhesins are specialized surface proteins that mediate bacterial colonization. They specifically recognize receptors on the target host-cell surfaces. Invasion following adhesion allows bacteria to evade the immune responses and to multiply in a well-protected niche (Niemann et al., 2004) .
The invasion of eukaryotic cells by uropathogenic Escherichia coli represents a complex biological phenomenon. The invasion process and gene products involved in it are poorly understood. Invasion of epithelial and endothelial cells may be important for the development of urosepsis. Invasiveness of some uropathogenic E. coli strains has been implicated in the pathogenesis of meningitis in the newborn (Meier et al., 1996) . Furthermore, experimental chronic pyelonephritis has been found to be associated with bacteria that persist in the kidney interstitial tissue. This may be advantageous for the bacteria, because they are protected against host defence mechanisms, such as complement, and certain antibiotics (Donnenberg et al., 1994) .
E. coli strains express various adhesins on the surface of the bacterial cells that mediate attachment to mammalian receptors. Among the most frequent adhesins in uropathogens are the Dr family of adhesins of E. coli. In particular, Dr fimbriae are associated with cystitis, pregnancy pyelonephritis and diarrhoeal diseases. The Dr family includes fimbrial adhesins, such as Dr haemagglutinin (DraE adhesin) and F1845, and afimbrial adhesins, such as AFA-I, -II, -III and -IV. Members of this family bind to the Dr a blood-group antigen present on decay-accelerating factor (DAF, CD55), a complement-regulatory and signalling molecule (Nowicki et al., 1989 Garcia et al., 1994; Van Loy et al., 2002a, b; Pettigrew et al., 2004) .
Dr fimbriae of uropathogenic E. coli are assembled via the highly conserved chaperone-usher pathway, which directs the synthesis of over 30 different adhesive organelles expressed by a multitude of pathogenic bacteria (Hung et al., 1996; Soto & Hultgren, 1999; Piątek et al., 2005) .
Genes important for the biogenesis of Dr fimbriae are encoded by the dra gene cluster (draA, draB, draC, draD, draP and draE). Dr fimbriae have been considered to be homopolymeric structures composed of DraE subunits. The process of biogenesis of Dr fimbriae requires the action of chaperone DraB and usher DraC. In the periplasm, the DraB protein interacts with fimbrial DraE subunits and, based on steric information contained in their structure, these subunits fold to a native, functional form. The DraE subunits lack an antiparallel b-strand, which is provided by the chaperone DraB as a parallel G1 b-strand in the donorstrand complementation process. Only DraE subunits in a complex with the DraB protein are able to polymerize on contact with usher DraC, which forms a pore in the outer membrane that allows the translocation of the fimbrial subunits to the cell surface. During polymerization, the incoming DraE subunit removes the chaperone from its complex with the last subunit of a growing polymer by donor-strand exchange (Piątek et al., 2005) .
The Dr fimbriae-coding region of uropathogenic E. coli is associated with unique invasive properties. Insertional mutants of draE (fimbrial structural gene), draC and draB (genes involved in fimbrial biogenesis) and draD (invasin gene) were unable to enter HeLa cells. Complementation of the dra mutations with plasmid pBJN406 containing the dra operon restored and increased invasion (Goluszko et al., 1997b) .
The aim of this study was to determine the role of the DraC usher protein, which forms the outer-membrane channel, in the translocation of DraD invasin at the E. coli cell surface. Firstly, the investigations showed that mutation of draC, encoding the channel, affected the translocation of DraE fimbrial subunits, but did not disrupt export of DraD to the surface of bacterial cells. Secondly, the biogenesis of Dr fimbriae did not require the presence of the DraD protein.
METHODS
Bacterial strains, plasmids, enzymes and reagents. Overexpression was carried out in E. coli BL21(DE3) that does not express Lon or OmpT proteases (Novagen).
Bacterial cells were grown in L broth (LB) without glucose or on Luria agar (LA) plates (LB containing 1?5 % agar) supplemented with the appropriate antibiotics (Sigma).
Plasmid pBJN406, carrying the whole dra operon, and its transposon mutants with a mutation in the draE gene (draE : : TnPhoA) (pBJN17), draD gene (draD : : TnPhoA) (pBJN16) or draC gene (draC : : Tn5) (pBJN417) were described previously (Nowicki et al., 1987 (Nowicki et al., , 1989 ( Table 1) .
Plasmids pCC90, corresponding to the dra operon with its promoter region and regulatory genes upstream of the draB gene deleted, and pCC90D54stop, with a mutated draE gene (GAC triplet of the draE gene encoding Asp-54 was replaced with a stop codon), were provided by S. Moseley, University of Washington, Seattle, WA, USA (Carnoy & Moseley, 1997) (Table 1 ). The pCC90 plasmid was constructed in order to eliminate differences in protein expression among mutants as a result of methylation-dependent phase variation that occurs in the promoter region of adhesins (Braaten et al., 1994; van der Woude & Low, 1994) .
Plasmid pCC90DraDmut (the DraD-negative mutant), containing the dra gene cluster, was constructed by replacement of the draD gene by an amplification product (SacI-digested PCR product) in which a stop codon was created in the three reading frames (the resulting plasmid was sequenced) (Table 1) .
Plasmid pCC90DraCmut, containing the dra gene cluster with a deletion of the region upstream of draB and a mutated draE gene, was constructed by site-directed mutagenesis [DraC-K11stop mutant, where the AAA triplet of the draC gene encoding Lys-11 was replaced with a TGA stop codon by using a QuikChange site-directed mutagenesis kit (Stratagene)] (the resulting plasmid was sequenced) ( Table 1 ).
An insertional draC mutant, E. coli DR14, of the clinical E. coli isolate IH11128 bearing Dr fimbriae was described previously (Goluszko et al., 1997a) (Table 1) . This strain has lost adherence functions of the Dr haemagglutinin. PCR amplification and cloning of the draD gene forms. The draD gene forms, encoding bacterial DraD invasin, were prepared by PCR amplification using the DNA of plasmid pBJN406 as a template. The primers used in the amplification were designed based on the sequencing data obtained (GenBank accession no. AF329316). For amplification of the draDsyg gene, the following primers were used: DraD-syg-1 forward primer, ATAGGTACCCATATGCGT-GTCACCTGCGGG (the underlined sequence contains recognition sequences for KpnI and NdeI endonucleases and the bold part is complementary to the nucleotide sequence at the 59 end of the draD gene) and DraD2-C-His reverse primer, TGCAAGCTTTT-CCTGTGGCACCACACA (the underlined sequence contains the recognition sequence for HindIII endonuclease and the bold part is complementary to the nucleotide sequence at the 39 end of the draD gene). For amplification of the draDsygstop gene, the following primers were used: DraD-syg-1 forward primer and DraDsygstop-2 reverse primer, TGCGGATCCTCATTCCTGTGGCACCACACA (the underlined sequence contains the recognition sequence for BamHI endonuclease, the italicized sequence encodes a stop codon and the bold part is complementary to the nucleotide sequence at the 39 end of the draD gene).
The genes were amplified by using 35 cycles of PCR (94 uC for 30 s, 52 uC for 30 s and 72 uC for 30 s, in a Perkin-Elmer 2400 thermocycler). The draDsyg (438 bp) and draDsygstop (441 bp) PCR products, purified from the agarose-gel bands by using a DNA Gel-Out kit (A&A Biotechnology), digested with KpnI and HindIII/BamHI restriction enzymes (BioLabs) and purified by using a DNA Clean Up kit (A&A Biotechnology), were cloned directionally into the KpnI and HindIII/BamHI sites of pET-30 Ek/LIC vector (the genes are out of frame in this construct). These plasmids were then digested with NdeI endonuclease and ligated in the presence of KpnI endonuclease to provide the genes in-frame. The resulting recombinant plasmids were designated pInvDsyg-C-His and pInvDsygstop, respectively.
PCR amplification and cloning of the dra DNA fragment used for replacement of the draD gene encoded by the pCC90 plasmid. In order to obtain the pCC90DraDmut plasmid, the DNA fragment of the dra gene cluster (containing the DNA fragment of the draD gene with a stop codon in the three reading frames, the draP gene and a DNA fragment of the draE gene) was amplified by using pBJN406 as a template. Sequences of the primers used to amplify the selected dra DNA fragment were: DraD-SacKpn forward primer GAGCTCGGTACCTGATTGATTGACAGGTGGAC-GGCAGGGCGGAG (the underlined sequence contains recognition sequences for SacI and KpnI endonucleases, permitting cloning of the SacI PCR product into plasmid pCC90, the bold parts of the primer sequence indicate stop codons in the three reading frames and the italicized portion of the primer sequence is complementary to the nucleotide sequence of the draD gene) and DraD-SacEco reverse primer GTCGAATTCGAGCTCACGGCGAACACCATGC (the underlined sequence contains recognition sequences for EcoRI and SacI endonucleases, permitting cloning of the SacI PCR product into plasmid pCC90, and the italicized portion of the primer sequence is complementary to the nucleotide sequence of the draE gene). The primers enabled the introduction of a SacI-digested PCR product into plasmid pCC90.
The selected region of the dra operon was amplified by using 30 cycles of PCR (94 uC for 30 s, 70 uC for 30 s and 72 uC for 30 s, in a PerkinElmer 2400 thermocycler). The 1078 bp PCR product, purified from an agarose-gel band by using a DNA Gel-Out kit (A&A Biotechnology), digested with SacI restriction enzyme (BioLabs) and purified by using a DNA Clean Up kit (A&A Biotechnology), was cloned directionally into the SacI sites of plasmid pCC90. The resulting recombinant plasmid, pCC90DraDmut, was selected by electrophoretic-mobility analysis, confirmed by restriction analysis and sequenced by using an automatic sequencing system (ABI Prism 377; Applied Biosystems).
Site-directed mutagenesis and construction of the pCC90DraCmut plasmid. The AAA triplet of the draC gene encoding Lys-11 was replaced with a stop codon (TGA) by using a QuikChange site-directed mutagenesis kit (Stratagene), following the manufacturer's instructions. Two primers containing the desired mutation (underlined), DraC1mut forward (GCGGCCATGCT-GTGAGGTGGCGGGAAGG) and DraC2mut reverse (CCTTCCCG-CCACCTCACAGCATGGCCGC), were designed based on the sequencing data obtained (GenBank accession no. AF329316). Plasmid pCC90 was used as the template to introduce the mutation into draE. Mutation was confirmed by DNA sequencing using an ABI Prism 377 system.
Antisera. Rabbit anti-Dr adhesin antibodies raised against purified native Dr fimbriae (Pham et al., 1997) and rabbit anti-DraD invasin antibodies raised against purified DraD-C-His 6 protein (Zalewska et al., 2001) were described previously. Anti-rabbit IgG (whole molecule) antibodies conjugated to horseradish peroxidase were purchased from Sigma. Anti-rabbit IgG (whole molecule)-tetramethylrhodamine isothiocyanate (TRITC) conjugate and antirabbit IgG (whole molecule)-fluorescein isothiocyanate (FITC) conjugate were purchased from Sigma.
Detection of free thiols and disulfide bonds. To detect disulfide bonds, 2 nM mature DraD-C-His 6 protein per reaction was used. Detection of disulfide bonds was performed as described previously (Piątek et al., 2005) .
Purification of Dr fimbriae. The recombinant plasmid pCC90DraDmut, encoding the dra gene cluster with a deletion of the region upstream of draB with a mutated draD gene, was introduced into E. coli BL21(DE3) and grown on LA plates with the appropriate antibiotic (100 mg ampicillin ml
21
) at 37 uC for 24 h. Dr fimbrial protein was isolated by heat-shock treatment, ammonium sulfate precipitation and size-exclusion chromatography, as described previously (Goluszko et al., 1999) . Protein concentration was determined by densitometric analysis with an SDS-PAGE lowmolecular-weight calibration kit (Amersham Biosciences) as a standard, using a VersaDoc system with Quantity One software (both from Bio-Rad).
The recombinant E. coli BL21(DE3)-pCC90 strain was used as a positive control for Dr fimbriae expression. The recombinant strains of E. coli BL21(DE3)-pCC90D54stop and E. coli BL21(DE3)-pCC90DraCmut (not expressing Dr fimbriae at the cell surface) were used as negative controls.
Western blot analysis. The samples were mixed with sample buffer and run in 15 % (w/v) bis-acrylamide gels containing SDS. The proteins were electroblotted onto nitrocellulose membranes and incubated with rabbit anti-Dr adhesin serum at a 1 : 5000 dilution or rabbit anti-DraD serum at a 1 : 1000 dilution. Blots were visualized as described previously (Zalewska et al., 2003) .
Immunofluorescence microscopy (IFM). Cells from cultures grown on LA plates at 37 uC for 24 h were harvested and washed gently in PBS. Bacterial suspensions (100 ml; 10 5 -10 6 cells ml 21 ) were incubated with 50 ml of a 1 : 500 dilution (anti-fimbriae Dr) or 1 : 250 dilution (anti-DraD invasin) in PBS of the primary antibodies at room temperature for 1 h. The reaction mixtures were then washed three times with PBS containing 10 % (v/v) glycerol and incubated with 50 ml of a 1 : 25 dilution (anti-rabbit IgG-TRITC conjugate for the DraD protein) or 1 : 50 dilution (anti-rabbit IgG-FITC conjugate for the DraE protein) in PBS of secondary antibodies at room temperature for 1 h. The reaction mixtures were then washed again three times with PBS containing 10 % (v/v) glycerol. Bacterial suspensions (10 ml) were loaded on glass slides and observed with an immunofluorescence microscope (Olympus BX-60).
RESULTS

Immunological detection of DraE
A summary of IFM testing for DraE adhesin in E. coli strains harbouring the recombinant plasmids is shown in Table 2 . The performed experiments present surface expression of DraE independent of DraD, which has never been visualized before for the dra gene cluster. Similar results were obtained previously for the homologous afa-3 gene cluster (Garcia al., 1996) . However, AfaE-III and DraE differ in sequence by only three amino acids (positions 52, 88 and 111 in the mature adhesin) and possess significantly different properties, which are critical for a different morphological structure -afimbrial and fimbrial, respectively. DraE has been reported to bind to the 7s domain of type IV collagen, but AfaE-III has not. Binding of DraE to both DAF and type IV collagen is blocked by the presence of chloramphenicol, whereas the binding of AfaE-III to DAF is unaffected (Westerlund et al., 1989) . Additionally, taking into consideration the suggestion of Anderson et al. (2004) that DraD is a tip subunit capping fimbriae composed of DraE subunits, DraD protein could be an initiator subunit of Dr fimbriae biogenesis. Therefore, lack of the DraD tip subunit could block the polymerization of DraE subunits into the fimbrial structure.
In the experiments, E. coli BL21(DE3)-pCC90 strain, which expresses wild-type Dr fimbriae, was used as a positive control and E. coli BL21(DE3), E. coli BL21(DE3)-pCC90D54stop and E. coli BL21(DE3)-pCC90DraCmut strains were used as negative controls (lack of surface DraE adhesin expression). The pCC90D54stop (Carnoy & Moseley, 1997) and pCC90DraCmut (this work) plasmids were constructed by site-directed mutagenesis. The stop mutations caused a lack of DraE expression at the cell surface (pCC90D54stop) or accumulations of chaperone DraB-subunit DraE complexes in the periplasm, without translocation and assembly of the fimbrial subunits into homopolymeric, surface-located structures (pCC90DraCmut). The ability of the E. coli BL21(DE3) strain transformed with the pCC90DraDmut plasmid (not producing DraD protein) to express native Dr fimbriae was confirmed by immunoblotting analysis (Fig. 1, lane 7) and IFM (Fig. 2e) .
In Western blotting, the fimbria-specific rabbit anti-Dr antibodies recognized DraE fimbrial proteins isolated from the surface of bacterial cells (in both pCC90 and pCC90DraDmut) (Fig. 1, lanes 5 and 7) . However, the purified rabbit anti-DraD (raised against DraD) did not react with DraE fimbrial fractions (in either pCC90 or pCC90DraDmut) (data not shown). The absence of fimbrial subunits at the surface of bacterial cells was observed in BL21(DE3) (data not shown), BL21(DE3)-pCC90D54stop
( Fig. 1, lane 1) and BL21(DE3)-pCC90DraCmut (Fig. 1,  lane 3) E. coli strains. In the case of E. coli BL21(DE3)-pCC90DraCmut, the DraE fimbrial subunits were accumulated in the periplasm (Fig. 1, lane 4) . Immunofluorescence staining of E. coli cells carrying plasmids pCC90 or pCC90DraDmut with rabbit anti-Dr and anti-rabbit-FITC antibodies showed expression of the DraE protein at the cell surface (Fig. 2c, e) . Surface expression of DraE was not detected in the wild-type E. coli BL21(DE3) strain (Fig. 2a) , E. coli BL21(DE3)-pCC90D54stop (not producing the functional DraE fimbrial subunit; Fig. 2g ) or E. coli BL21(DE3)-pCC90DraCmut (not producing an outermembrane DraC protein, allowing the translocation of DraE subunits to the cell surface; Fig. 2i) . The E. coli BL21(DE3) strain incubated with PBS instead of anti-Dr antibodies showed a weak, non-specific, diffuse fluorescence (negative control). The immunofluorescence experiments were conducted in comparison with E. coli BL21(DE3)-pBJN406, containing the entire dra gene cluster (Fig. 2k ), E. coli BL21(DE3)-pBJN16 with a transposon-insertion mutation within the draD gene (positive control for DraE surface expression; Fig. 2m ), E. coli BL21(DE3)-pBJN417 with a transposon-insertion mutation within the draC gene ( Fig. 2o ) and E. coli BL21(DE3)-pBJN17 with a transposoninsertion mutation within the draE gene (negative control for DraE surface expression; Fig. 2r ). We detected DraE surface expression for E. coli BL21(DE3)-pBJN406 and BL21(DE3)-pBJN16 strains subjected to phase variation, in which some bacteria express Dr fimbriae and other cells do not (Fig. 2k, m) .
The obtained results suggest that expression of Dr fimbriae at the bacterial cell surface did not require DraD. These data also revealed that, in appropriate mutants, the expression of DraE fimbrial subunits was independent of DraD expression. Conversely, DraD expression was also independent of DraE expression. The lack of immuno-identification of DraD protein in the isolated Dr fimbrial fractions suggests that the majority of Dr fimbrial structures were probably composed of DraE fimbrial subunits only, and that the majority of the DraD protein may be independent components of the cell surface. Alternatively, in an intact dra operon, a small fraction of the DraD protein may be used to cap the fimbrial structures at the surface of bacterial cells, as proposed recently by Anderson et al. (2004) . The concentration of tip DraD may be very low and difficult to detect in the presence of hundreds of DraE structural subunits forming fimbrial fibre.
Defining the role of DraC in the translocation mechanism of DraD A summary of IFM results of DraD surface expression for E. coli strains harbouring the recombinant plasmids is described in Table 2 . By using site-directed mutagenesis, we constructed the recombinant plasmid pCC90DraCmut to determine the function of DraC (the outer-membrane channel) in the translocation of DraD invasin at the E. coli Dr + cell surface. pCC90DraCmut encodes the dra gene cluster without a regulatory region and with a stop codon within the draC gene. IFM with rabbit anti-Dr (anti-Dranti-FITC) and anti-DraD (anti-DraD-anti-TRITC) antibodies detected the presence of only DraD on the surface of E. coli BL21(DE3) cells harbouring recombinant plasmid pCC90DraCmut (Figs 2i and 3i) . We obtained the same result with E. coli BL21(DE3) cells transformed with pBJN417, encoding the entire dra gene cluster with a transposon-insertion mutation within the draC gene (draC : : Tn5) (Figs 2o and 3o) . IFM analysis of the insertional draC mutant of the clinical E. coli isolate IH11128 (E. coli DR14) detected the presence of only DraD on the surface of cells (Figs 2t and 3t) . The ability of E. coli DR14 strain to express DraE and DraD proteins was tested by immunoblotting analysis. The fimbria-specific rabbit anti-Dr antibodies recognized DraE fimbrial protein and the purified rabbit anti-DraD recognized DraD protein in the E. coli DR14 total lysate (results not shown). Based on these experiments, we concluded that the DraC protein was not required in the transport of the DraD to the bacterial surface. E. coli BL21(DE3)-pCC90, encoding the dra gene cluster without a regulatory region (Fig. 3c) , BL21(DE3)-pBJN406 strain, encoding the entire dra gene cluster (Fig. 3k) , and BL21(DE3)-pCC90D54stop (Fig. 3g) and BL21(DE3)-pBJN17 with the inactivated draE gene (Fig. 3r) were used as positive controls for DraD surface expression. For negative controls, we used E. coli BL21(DE3) not expressing the dra gene cluster (Fig. 3a) and BL21(DE3)-pCC90DraDmut ( Fig. 3e) and BL21(DE3)-pBJN16 with the inactivated draD gene (Fig. 3m) . To our knowledge, this is the first report to identify the DraD protein on the bacterial surface by using draC and/or draE E. coli mutants.
To further investigate our hypothesis that DraD expression at the bacterial cell surface is independent of DraE fimbrialsubunit production and does not require contact with the outer-membrane DraC channel, by which the polymerization process of Dr fimbriae occurs, we constructed pInvDsyg-C-His and pInvDsygstop recombinant plasmids. These plasmids encode DraD invasin with its N-terminal signal sequence and a polyhistidine domain at the C terminus of the protein or without any fusion domain, respectively (Table 1 ). The N-terminal signal sequence is removed during export of the protein from cytoplasm across (b, d, f, h, j, l, n, p, s, u, w, y) phase-contrast micrographs of the above bacterial cells. Magnification 610 000, Olympus BX-60.
the inner membrane into the periplasm of E. coli cells. IFM of E. coli BL21(DE3)-pInvDsyg-C-His with anti-DraD antibodies revealed that the DraD protein was also expressed at the cell surface (Fig. 3v) . Induction by IPTG of the inoculated culture resulted in fluorescence, which appeared to be localized to the intensely stained cluster corresponding to aggregated bacterial cells visualized in the parallel-phase microscope field. The observed effect did not influence bacterial growth or cell viability (data not shown). A possible explanation for the anomalous fluorescence of the studied cells could be connected with the overexpression level of the DraD protein in recombinant strains, which far exceeds those reached under physiological conditions for clinical E. coli strains, also encoding other Dra components besides DraD. Similar results were obtained for E. coli BL21(DE3)-pInvDsygstop (Fig. 3x) . The conducted investigations indicated that the presence of a polyhistidine domain at the C terminus of DraD invasin did not influence translocation of the protein at the surface of bacterial cells. Electron-microscopic studies of polystyrene beads coated with periplasmic DraD-C-His also revealed aggregation in a concentration-dependent manner. DraD-coated beads entered HeLa cells in the form of conglomerates containing three to five beads (data not shown).
DISCUSSION
The work described here characterized the role of the outermembrane DraC channel (encoded by the dra gene cluster) in the export of DraD. Dr fimbriae are assembled via the highly conserved chaperone-usher pathway (Piątek et al., 2005) . Both the chaperone and the usher, DraB and DraC in the Dr fimbriae system, are absolutely required for Dr fimbriae biogenesis to occur, as mutations in either gene result in non-piliated bacteria. Therefore, we constructed pCC90DraCmut, a recombinant plasmid encoding the dra gene cluster (without a regulatory region) and with a stop codon within the draC gene, causing premature translation termination of DraC usher. IFM examinations with rabbit anti-Dr (anti-Dr-anti-FITC) and anti-DraD (anti-DraDanti-TRITC) antibodies detected the presence of only DraD invasin on the surface of E. coli BL21(DE3) cells harbouring the pCC90DraCmut plasmid. We obtained the same result in the case of E. coli BL21(DE3) cells transformed with pBJN417 (Nowicki et al., 1989) , encoding the entire dra gene cluster with a transposon-insertion mutation within the draC gene, and a clinical E. coli DR14 (Goluszko et al., 1997a) insertional draC mutant. The mutation inactivating the draC gene caused the accumulation of DraE fimbrial subunits bound to DraB chaperone in the periplasm (detected by Western blotting analysis). Immunofluorescence labelling of the cells of the studied E. coli strains with anti-Dr antibodies did not reveal surface expression of the DraE fimbrial subunits. The obtained results suggested that DraC usher, which forms a pore in the outer membrane, allowing translocation and polymerization of DraE fimbrial subunits at the cell surface, was not required for the surface export of DraD. To confirm our supposition, we constructed a recombinant plasmid encoding DraDsyg invasin with a polyhistidine domain at the C terminus and a plasmid encoding a native DraD without a fusion domain. The conducted investigations confirmed our hypothesis about the translocation of DraD protein across the outer membrane to the cell surface without the presence of functional DraC usher. IFM examinations of whole-mount cells of E. coli strains harbouring pInvDsyg-C-His and pInvDsygstop plasmids, encoding only the functional draD gene, showed the surface expression of DraD protein, a phenomenon that has not been visualized before. The performed investigations also showed that the polyhistidine domain of the studied recombinant DraD proteins did not influence the export of DraD to the surface of bacterial cells. Additionally, detection of the disulfide bond between two conserved cysteines (Cys-28 and Cys-116, homologous to Cys residues of the AfaD-like family of invasins; Garcia et al., 2000) of the mature DraD protein may indicate correct folding of the studied protein. For comparison, parallel experiments were conducted with transposon-insertion mutations inactivating the draE, draD and draC genes of the dra gene cluster. Dr fimbriae have been considered as homopolymeric structures composed of repeating monomers of DraE fimbrial subunits. A recent study by Anderson et al. (2004) suggested that DraD may be a tip protein capping the DraE fibre. Until now, very little has been known about the expression and role of DraD in the biogenesis of Dr fimbriae. In this study, we have constructed several plasmids encoding the dra gene cluster and used them to study the expression and biogenesis of Dr fimbriae without the presence of functional DraD.
The obtained results revealed that the level of DraE surface expression from our constructs was similar to those from the pCC90 plasmid (Carnoy & Moseley et al., 1997) . The E. coli strain harbouring pCC90D54stop (Carnoy & Moseley et al., 1997) with a mutated draE gene was used to characterize the expression of DraD invasin. These experiments showed that the surface expression of DraD in draE mutants was independent of DraE (fimbriae) expression. Conversely, the ability of E. coli BL21(DE3)-pCC90DraDmut (producing no DraD) to express native Dr fimbriae was not affected, as confirmed by Western blotting and IFM with purified rabbit anti-Dr antibodies recognizing DraE adhesin. The anti-DraD antibodies (recognizing epitopes of DraD invasin) did not react with the purified Dr fimbrial fractions isolated from the surface of the studied E. coli cells. The obtained results may indicate a few alternative scenarios. One option is that the DraD protein is not a component of Dr fimbriae and has independent, surfacelocated structures. An alternative explanation is that DraD is a tip subunit capping a homopolymeric fibre composed of DraE fimbrial subunits, as suggested by Anderson et al. (2004) . Because the concentration of hundreds of DraE structural subunits forming the fimbrial fibre is disproportionally higher than the concentration of a tip subunit, the identification of DraD protein in the described samples was not possible, as its level was below the sensitivity of the method used. The analyses performed with DraD-or DraEnegative mutants also indicated that the expression of one protein at the surface of bacterial cells did not require production of the other. This does not, however, exclude the third possibility that DraD may be expressed in two forms (fimbriae-associated and not fimbriae-associated) and that cooperation between DraE and DraD may be beneficial for E. coli invasion, as confirmed by Goluszko et al. (1997b) . The performed experiments revealed that insertional mutants of draE, draD, draC, draB and UV-inactivated pBJN406 lost their invasiveness and were unable to enter HeLa cells, suggesting a role for the draE gene and one or more dra genes in this process. Only the draD mutant retained weak haemagglutination and HeLa-adherence properties (about four or five bacteria per HeLa cell) (Goluszko et al., 1997b) .
The obtained data indicate that the export of DraD protein to the cell surface (in the draC mutant) does not involve the DraC outer-membrane usher protein. Our results demonstrated also for the first time that, in the absence of DraD, the DraE adhesin of uropathogenic E. coli was surface-exposed independently. Expression of the DraE fimbrial protein at the cell surface does not require expression of the DraD protein and, conversely, the surface expression of DraD does not require DraE adhesin expression. Identification of the specific protein forming a pore in the outer membrane, allowing the translocation of DraD subunits to the cell surface, will be the next step of our research. This will be very important for increasing our understanding of the invasion process and the role of independent expression of DraE and DraD proteins in the pathophysiology of infections caused by E. coli strains of the Dr family.
